BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33972990)

  • 41. Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study.
    Bissolati M; Desio M; Rosa F; Rausei S; Marrelli D; Baiocchi GL; De Manzoni G; Chiari D; Guarneri G; Pacelli F; De Franco L; Molfino S; Cipollari C; Orsenigo E
    Gastric Cancer; 2017 Jan; 20(1):70-82. PubMed ID: 26732876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
    Lagarde SM; Phillips AW; Navidi M; Disep B; Griffin SM
    Dis Esophagus; 2017 Dec; 30(12):1-7. PubMed ID: 28881884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of circumferential resection margin involvement in patients receiving potentially curative treatment for oesophageal cancer.
    Quinn LM; Hollis AC; Hodson J; Elshafie MA; Hallissey MT; Whiting JL; Griffiths EA
    Eur J Surg Oncol; 2018 Aug; 44(8):1268-1277. PubMed ID: 29843937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Surgical outcomes of esophageal cancer resection since the development of an Oesophagogastric Tumour Board].
    Farran Teixidor L; Llop Talaverón J; Galán Guzmán M; Aranda Danso H; Miró Martín M; Bettónica Larrañaga C; Estremiana García F; Biondo S
    Cir Esp; 2013 Oct; 91(8):517-23. PubMed ID: 23583091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic review and meta-analysis of the influence of circumferential resection margin involvement on survival in patients with operable oesophageal cancer.
    Chan DS; Reid TD; Howell I; Lewis WG
    Br J Surg; 2013 Mar; 100(4):456-64. PubMed ID: 23319427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
    Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
    Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment strategies in recurrent esophageal or junctional cancer.
    Butter R; Lagarde SM; van Oijen MGH; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Berge Henegouwen MI; van Laarhoven HWM
    Dis Esophagus; 2017 Sep; 30(9):1-9. PubMed ID: 28859371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical management of esophageal sarcoma: a multicenter European experience.
    Mege D; Depypere L; Piessen G; Slaman AE; Wijnhoven BPL; Hölscher A; Nilsson M; van Berge Henegouwen MI; van Lanschot JJB; Schroeder W; Thomas PA; Nafteux P; D'Journo XB
    Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29444281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative study of survival after minimally invasive and open oesophagectomy.
    Burdall OC; Boddy AP; Fullick J; Blazeby J; Krysztopik R; Streets C; Hollowood A; Barham CP; Titcomb D
    Surg Endosc; 2015 Feb; 29(2):431-7. PubMed ID: 25125095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meta-analysis of the influence of a positive circumferential resection margin in oesophageal cancer.
    Evans R; Bundred JR; Kaur P; Hodson J; Griffiths EA
    BJS Open; 2019 Oct; 3(5):595-605. PubMed ID: 31592511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical management of and long-term survival after adenocarcinoma of the cardia.
    Mariette C; Castel B; Toursel H; Fabre S; Balon JM; Triboulet JP
    Br J Surg; 2002 Sep; 89(9):1156-63. PubMed ID: 12190682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy.
    Dresner SM; Griffin SM
    Br J Surg; 2000 Oct; 87(10):1426-33. PubMed ID: 11044172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.
    Sasaki K; Margonis GA; Andreatos N; Wilson A; Weiss M; Wolfgang C; Sergentanis TN; Polychronidis G; He J; Pawlik TM
    Br J Surg; 2017 Jun; 104(7):926-935. PubMed ID: 28266705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abandoning resectional intent in patients initially deemed suitable for esophagectomy: a nationwide study of risk factors and outcomes.
    Edholm D; Lindblad M; Linder G
    Dis Esophagus; 2021 Mar; 34(3):. PubMed ID: 32960273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
    Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
    Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic value of circumferential resection margin involvement in oesophageal malignancy.
    Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
    Eur J Surg Oncol; 2006 May; 32(4):413-9. PubMed ID: 16504455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimally Invasive Circumferential Hiatal Dissection for the Treatment of Adenocarcinoma of the Distal Esophagus and Esophago-gastric Junction: Technical Considerations Combined With Histopathological Outcomes.
    Lorenzi B; Davakis S; Syllaios A; Kordzadeh A; Kadri M; Ram M; Fareed K; Barter C; Charalabopoulos A
    Anticancer Res; 2019 Jun; 39(6):3219-3225. PubMed ID: 31177171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trends and results of oesophageal cancer surgery in Finland between 2004 and 2014.
    Helminen O; Sihvo E; Gunn J; Sipilä JOT; Rautava P; Kytö V
    Eur J Cardiothorac Surg; 2020 Jan; 57(1):107-113. PubMed ID: 31263881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of operative approach for oesophageal cancer on outcome: the transhiatal approach may influence circumferential margin involvement.
    Suttie SA; Nanthakumaran S; Mofidi R; Rapson T; Gilbert FJ; Thompson AM; Park KG
    Eur J Surg Oncol; 2012 Feb; 38(2):157-65. PubMed ID: 22154884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
    Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
    Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.